2018-10-17 - Unknown
719252
| Adverse reaction report number | 719252 |
| Latest AER version number | 0 |
| Market authorization holder AER number | 626963 |
| Initial received date | 2018-10-17 |
| Latest received date | 2018-10-17 |
| Age | N/A |
| Gender | Unknown |
| Weight | N/A |
| Type of report | Study |
| Reporter type | Physician |
| Source of report | MAH |
| Report outcome | Unknown |
| Serious report? | No |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| OZEMPIC | SOLUTION SUBCUTANEOUS | Suspect | Unknown | Diabetes mellitus |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Drug ineffective | |
| Glycosylated haemoglobin increased | |